|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM237623439 |
003 |
DE-627 |
005 |
20250216230405.0 |
007 |
tu |
008 |
231224s2014 xx ||||| 00| ||jpn c |
028 |
5 |
2 |
|a pubmed25n0792.xml
|
035 |
|
|
|a (DE-627)NLM237623439
|
035 |
|
|
|a (NLM)24759503
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a jpn
|
100 |
1 |
|
|a Yoshida, Yasuyuki
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a A case of urachal carcinoma with multiple lung metastases treated by TS-1/CDDP chemotherapy
|
264 |
|
1 |
|c 2014
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 11.06.2014
|
500 |
|
|
|a Date Revised 24.04.2014
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a A 67-year-old woman presented with macroscopic hematuria and lower abdominal pain. Cystoscopy revealed a broad-stalk non-papillary tumor at the bladder dome. Computed tomography (CT) showed a tumor extending from the umbilicus to the bladder dome, together with multiple lung metastases. Serum carcinoembryonic antigen and cancer antigen (CA19-9) levels were elevated at 7.0 ng/ml and 180 U/ml, respectively. Transurethral resection of the tumor was performed and histopathology revealed adenocarcinoma. Therefore, the tumor was diagnosed as a stage IVB (Sheldon's category) urachal carcinoma. En bloc segmental resection of the urachal carcinoma with the bladder dome was performed, followed by chemotherapy with tegafur, gimestat, and otastat potassium (TS-1) and cisplatin. The disease remained stable for 8 months. However, a follow up CT scan after 11 chemotherapy cycles showed progression of the lung metastases. In spite of the change to a second-line gemcitabine and cisplatin chemotherapy regimen, the disease continued to progress after 4 cycles
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Antigens, Tumor-Associated, Carbohydrate
|2 NLM
|
650 |
|
7 |
|a Carcinoembryonic Antigen
|2 NLM
|
650 |
|
7 |
|a Drug Combinations
|2 NLM
|
650 |
|
7 |
|a carbohydrate antigen 199, human
|2 NLM
|
650 |
|
7 |
|a S 1 (combination)
|2 NLM
|
650 |
|
7 |
|a 150863-82-4
|2 NLM
|
650 |
|
7 |
|a Tegafur
|2 NLM
|
650 |
|
7 |
|a 1548R74NSZ
|2 NLM
|
650 |
|
7 |
|a Oxonic Acid
|2 NLM
|
650 |
|
7 |
|a 5VT6420TIG
|2 NLM
|
700 |
1 |
|
|a Yamanaka, Kazuaki
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ueda, Norichika
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hirai, Toshiaki
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kishikawa, Hidefumi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Nishimura, Kenji
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ichikawa, Yasuji
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 60(2014), 3 vom: 15. März, Seite 147-50
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
773 |
1 |
8 |
|g volume:60
|g year:2014
|g number:3
|g day:15
|g month:03
|g pages:147-50
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2018
|
951 |
|
|
|a AR
|
952 |
|
|
|d 60
|j 2014
|e 3
|b 15
|c 03
|h 147-50
|